loadpatents
Patent applications and USPTO patent grants for AptaBio Therapeutics Inc..The latest application filed is for "composition for treating eye diseases".
Patent | Date |
---|---|
Composition For Treating Eye Diseases App 20220218685 - Ki; Min-hyo ;   et al. | 2022-07-14 |
Crystalline solid compound of 3-phenyl-4-propyl-1-(pyridin-2-yl)-1H-pyrazol-5-ol hydrochloride Grant 11,174,240 - Moon , et al. November 16, 2 | 2021-11-16 |
Novel Crystalline Solid Compound Of 3-phenyl-4-propyl-1-(pyridin-2-yl)-1h-pyrazol-5-ol Hydrochloride App 20210122726 - Moon; Sung Hwan ;   et al. | 2021-04-29 |
Therapeutic agent for liver diseases Grant 10,966,969 - Moon , et al. April 6, 2 | 2021-04-06 |
Therapeutic Agent For Liver Diseases App 20200390752 - Moon; Sung Hwan ;   et al. | 2020-12-17 |
Guanosine-rich modified oligonucleotides and antiproliferative activity thereof Grant 9,056,886 - Lee , et al. June 16, 2 | 2015-06-16 |
Novel Guanosine-rich Modified Oligonucleotides And Antiproliferative Activity Thereof App 20120202981 - Lee; Soo Jin ;   et al. | 2012-08-09 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.